In 2022, the President signed the Formula Act (H.R. 8351) and the Bulk Infant Formula to Retail Shelves Act (H.R. 8982). These acts provided for the temporary duty-free treatment of infant formula and infant formula base powder, respectively. Below CSMS messages are CBP's guidance for the implementation of the temporary duty-free treatment. The duty-free treatment expired on December 31, 2022.
Temporary Duty-Free Treatment of Infant Formula and Infant Formula Base Powder
Last Modified: Aug 03, 2023